What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Disease
His primary scientific interests are in Twin study, Demography, Psychiatry, Heritability and Monozygotic twin.
His biological study spans a wide range of topics, including Odds ratio, Multivariate analysis, Social environment, Clinical psychology and Drug.
Particularly relevant to Anxiety disorder is his body of work in Psychiatry.
His research integrates issues of Depression, Audiology, Nicotine and Endophenotype in his study of Heritability.
His Alcohol dependence study incorporates themes from Genetic determinism and Comorbidity.
The Risk factor study combines topics in areas such as Rheumatoid arthritis, Substance abuse, Veterans Affairs and Hazard ratio.
His most cited work include:
- The effect of prescribed daily dose frequency on patient medication compliance. (723 citations)
- Co-occurrence of Abuse of Different Drugs in Men The Role of Drug-Specific and Shared Vulnerabilities (597 citations)
- A Twin Study of Genetic and Environmental Contributions to Liability for Posttraumatic Stress Symptoms (556 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Psychiatry, Twin study, Demography, Internal medicine and Depression.
His work on Anxiety disorder and Comorbidity as part of general Psychiatry research is frequently linked to Monozygotic twin, thereby connecting diverse disciplines of science.
The study incorporates disciplines such as Developmental psychology, Odds ratio and Cognition in addition to Twin study.
Seth A. Eisen has included themes like Substance abuse and Confidence interval in his Odds ratio study.
In his research on the topic of Internal medicine, Heart disease is strongly related with Surgery.
His Dizygotic twin research includes themes of Genetic model, Social environment and Gene–environment interaction.
He most often published in these fields:
- Psychiatry (49.06%)
- Twin study (36.79%)
- Demography (21.70%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (25.47%)
- Veterans Affairs (7.55%)
- Family medicine (5.66%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Veterans Affairs, Family medicine, Surgery and Psychiatry.
His Internal medicine research includes elements of Peripheral neuropathy and Diabetes mellitus.
His work carried out in the field of Veterans Affairs brings together such families of science as Publishing, Career development, Curriculum, Lupus nephritis and Physical therapy.
His research in Surgery intersects with topics in Adalimumab, Head and neck cancer, Oncology, Lower risk and Infliximab.
In his research, Seth A. Eisen undertakes multidisciplinary study on Psychiatry and Combat exposure.
His studies deal with areas such as Etanercept, Rheumatoid arthritis and Risk factor as well as Retrospective cohort study.
Between 2011 and 2021, his most popular works were:
- Associations Between Obsessive-Compulsive Classes and Pathological Gambling in a National Cohort of Male Twins (58 citations)
- Environmental factors selectively impact co-occurrence of problem/pathological gambling with specific drug-use disorders in male twins. (56 citations)
- Myocardial Infarction Risk Among Patients With Fractures Receiving Bisphosphonates (15 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Disease
His primary areas of investigation include Retrospective cohort study, Internal medicine, Psychiatry, Cohort study and Risk factor.
His Retrospective cohort study study combines topics in areas such as Bisphosphonate and Cohort.
His Psychiatry study frequently draws connections between adjacent fields such as Social environment.
His Cohort study research incorporates elements of Osteoporosis, Hazard ratio, Physical therapy, Survival analysis and Veterans Affairs.
The concepts of his Risk factor study are interwoven with issues in Oncology, Lower risk, Infliximab and Etanercept, Rheumatoid arthritis.
His Etanercept research integrates issues from Adalimumab, Head and neck cancer and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
